The overall research mission of the Division of Addiction Psychiatry is to advance new treatments for drug and alcohol use disorders targeting prevention, drug withdrawal, relapse, and long-term abstinence, and to advance our understanding of the brain mechanisms that lead to and perpetuate drug and alcohol addiction. Internationally recognized researchers in Division of Addiction Psychiatry utilize state-of-the-art brain imaging and behavioral approaches to conduct innovating and ground-breaking clinical research and treatment intervention trials. Equally recognized leaders studying the basic neurobiology of addiction aim to advance our understanding of the brain circuits, cells, and molecules involved in the actions of drugs and alcohol on the brain, the interactions between environmental factors such as stress and drug addiction, and the basic neurobiology of brain reward systems thought to be “hijacked” by drugs of misuse. Our division researchers utilize a multidisciplinary and multi-level approach from molecules and cells, to preclinical animal studies, as well as clinical trials and prevention approaches to ultimately heal addiction and improve the lives of patients and their families.
Addiction affects our lives and the lives our loved ones in many ways. We hope you consider joining our effort to advance new treatment options for this devastating and too often fatal illness. To discuss how you can be a part of this mission please contact:
David E. Marcovitz, M.D.
Assistant Professor of Psychiatry
Director, Division of Addiction Psychiatry
or
Stephan Heckers, M.D.
Chairman, Department of Psychiatry